Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui

Bristol-Myers has signed a licensing deal worth up to $15 billion with Jiangsu Hengrui Pharmaceuticals. The deal is for branding and licensing of certain products. This partnership is expected to expand the reach of both companies.